Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03397394
Title Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma (ATLAS)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Clovis Oncology, Inc.
Indications

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

urethra transitional cell carcinoma

Therapies

Rucaparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.